Home › NDC Lookup › RxCUI directory › RxCUI 1724446

Acetaminophen 325 MG / butalbital 25 MG Oral Tablet — RxCUI 1724446

RxNorm drug concept · Semantic clinical drug
RxCUI 1724446 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1724446
Official nameAcetaminophen 325 MG / butalbital 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 325 MG / butalbital 25 MG Oral Tablet
FDA products mapped6
Package NDCs mapped9
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
  • Why am I getting acetaminophen through an IV instead of just taking a pill?
  • Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
  • The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...
📖 Read our full Acetaminophen Injection guide →

🕸️ Concept Web — How Acetaminophen 325 MG / butalbital 25 MG Oral Tab... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acetaminophen 325 MG / butalbital 25 MG Oral Tablet RxCUI 1724446

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Acetaminophen 161
    • Butalbital 19860
    • Acetaminophen / butalbital 214178
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Allzital 2279002
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acetaminophen / butalbital Oral Tablet 370514
    • Acetaminophen / butalbital Oral Product 1152259
    • Acetaminophen / butalbital Pill 1152260
    • Acetaminophen / butalbital Oral Tablet [Allzital] 2279004
    • Allzital Oral Product 2279005
    • Allzital Pill 2279006
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acetaminophen 325 MG SCDC · 315263
  • Butalbital 25 MG SCDC · 1724445
  • Acetaminophen / butalbital Oral Tablet SCDF · 370514
  • Acetaminophen / butalbital Oral Product SCDG · 1152259
  • Acetaminophen / butalbital Pill SCDG · 1152260

Brand-Name Concepts

📦 FDA Products & Package NDCs

6 products · 9 package NDCs
9 package NDCs map to RxCUI 1724446 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68047-0721-01 100 TABLET in 1 BOTTLE (68047-721-01) Butalbital And Acetaminophen Larken Laboratories, Inc. 2015-12-04
68047-0721-30 30 TABLET in 1 BOTTLE (68047-721-30) Butalbital And Acetaminophen Larken Laboratories, Inc. 2015-12-04
68047-0752-01 100 TABLET in 1 BOTTLE (68047-752-01) ALLZITAL Larken Laboratories, Inc. 2015-12-04
68047-0752-30 30 TABLET in 1 BOTTLE (68047-752-30) ALLZITAL Larken Laboratories, Inc. 2015-12-04
68047-0753-01 100 TABLET in 1 BOTTLE (68047-753-01) Butalbital and Acetaminophen Larken Laboratories, Inc. 2022-07-18
68047-0753-30 30 TABLET in 1 BOTTLE (68047-753-30) Butalbital and Acetaminophen Larken Laboratories, Inc. 2022-07-18
69292-0301-01 100 TABLET in 1 BOTTLE (69292-301-01) BUTALBITAL AND ACETAMINOPHEN Amici Pharma, Inc. 2026-03-15
69292-0302-01 100 TABLET in 1 BOTTLE (69292-302-01) BUTALBITAL AND ACETAMINOPHEN Amici Pharma, Inc. 2026-03-15
69292-0303-01 100 TABLET in 1 BOTTLE (69292-303-01) BUTALBITAL AND ACETAMINOPHEN Amici Pharma, Inc. 2026-03-15
Observed labelers: Larken Laboratories, Inc. (6) · Amici Pharma, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.